MAPT and Alzheimer disease: Since the pioneering work by Hirai et al. [77], mitochondrial morphological changes manifested as fragmented mitochondria with damaged inner membrane structures have been increasingly reported in neurons in AD patients [78] and AD experimental models overexpressing or treated with Aβ or tau [78,79,80,81,82,83].